拉斯米迪坦改善皮质-海马体病理,并改善老年帕金森症小鼠的认知能力

Atsushi Ishii1, Jasmine R Meredith2, Mandi J Corenblum1

  • 1Department of Neurology, College of Medicine, University of Arizona, Tucson, AZ, United States of America.

Experimental neurology
|October 14, 2025
PubMed
概括

拉斯米迪坦是一种5-HT1F受体激动剂,改善了帕金森氏症患者的认知缺陷和焦虑.